BI-RADS calculator: assessment categories and management
Choose a BI-RADS assessment category to see the management recommendation and likelihood of malignancy from the ACR BI-RADS Atlas, 5th edition. The full category table is below, so the assessment and the recommendation in your report can be checked against each other.
Need the whole report too? Type a few findings and get it written ↓
A sample dictation is ready below. Press generate, or type your own findings and end with “otherwise normal” to have the rest written out. No signup.
100 free reports over 14 days. No card, nothing to install.
Start your free trial →Please leave out patient identifiers. Text is de-identified before the AI sees it and is not stored. Demo output is not for clinical use.
BI-RADS assessment categories (5th edition)
| Category | Assessment | Management | Likelihood of malignancy |
|---|---|---|---|
| 0 | Incomplete: need additional imaging evaluation and/or prior mammograms for comparison | Recall for additional imaging and/or comparison with prior examinations | N/A |
| 1 | Negative | Routine screening | Essentially 0% |
| 2 | Benign | Routine screening | Essentially 0% |
| 3 | Probably benign | Short-interval (6-month) follow-up or continued surveillance | > 0% but ≤ 2% |
| 4A | Low suspicion for malignancy | Tissue diagnosis | > 2% to ≤ 10% |
| 4B | Moderate suspicion for malignancy | Tissue diagnosis | > 10% to ≤ 50% |
| 4C | High suspicion for malignancy | Tissue diagnosis | > 50% to < 95% |
| 5 | Highly suggestive of malignancy | Tissue diagnosis | ≥ 95% |
| 6 | Known biopsy-proven malignancy | Surgical excision when clinically appropriate | N/A |
Reporting notes
- Category 4 subdivisions. 4A, 4B and 4C are defined for mammography and ultrasound. The atlas does not subdivide category 4 for MRI.
- Category 0. Used mainly at screening. On diagnostic mammography or ultrasound it is reserved for the uncommon case where a further study is needed to complete the assessment; on MRI, for a technically inadequate study.
- Category 3. Reserved for findings with a specific probably benign appearance (for example a circumscribed oval parallel solid mass on ultrasound at baseline), assigned after a full diagnostic evaluation, not at screening.
- Management follows the category. Assessment and management should agree. A category 4 or 5 finding is followed by a recommendation for tissue diagnosis, not imaging follow-up.
Related
Worked example
Case. Diagnostic ultrasound at baseline shows a 9 mm oval, circumscribed, parallel solid mass with no suspicious features.
- Those are the features the atlas lists as probably benign for a solid mass on ultrasound at baseline.
- Category: BI-RADS 3, likelihood of malignancy above 0% but no more than 2%.
Result. Recommend short-interval (6-month) follow-up ultrasound. A finding that grows or gains a suspicious feature on follow-up is reassessed, usually as category 4.
Related calculators
Frequently asked questions
What does each BI-RADS category mean?
In the ACR BI-RADS Atlas, 5th edition: 0 is incomplete (additional imaging or prior comparison needed), 1 negative, 2 benign, 3 probably benign, 4 suspicious, 5 highly suggestive of malignancy and 6 known biopsy-proven malignancy. Categories 1 and 2 return to routine screening, 3 goes to short-interval follow-up, 4 and 5 to tissue diagnosis, and 6 to surgical excision when clinically appropriate.
What is the follow-up for BI-RADS 3?
BI-RADS 3, probably benign, carries a likelihood of malignancy above 0% but no more than 2%. Management is short-interval follow-up, conventionally at 6 months, followed by continued surveillance. It is assigned after a complete diagnostic evaluation, not from a screening examination alone.
What is the difference between BI-RADS 4A, 4B and 4C?
All three recommend tissue diagnosis. They differ in likelihood of malignancy: 4A is low suspicion (above 2% to 10%), 4B moderate (above 10% to 50%) and 4C high (above 50% to below 95%). The subdivisions are defined for mammography and ultrasound; category 4 is not subdivided for breast MRI.
MyRadAgent’s radiology AI drafts the full report and applies this guideline automatically, with the category and follow-up in the impression. Free trial runs in the browser: 100 reports over 14 days, no card, no IT ticket.
Try it on a report → or try it here first — no signup ↑BI-RADS, TI-RADS, LI-RADS, PI-RADS, O-RADS, Lung-RADS, CAD-RADS, NI-RADS and ACR are registered trademarks of the American College of Radiology. They are used here only to identify the published systems these tools implement; MyRadAgent is not affiliated with, sponsored by or endorsed by the ACR.